# Cevimeline Hydrochloride

NDC: 59651-422
Generic name: Cevimeline Hydrochloride
Labeler / Manufacturer: Aurobindo Pharma Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20230418

FDA application: ANDA215056

## Active ingredients

- CEVIMELINE HYDROCHLORIDE: 30 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"59651-422"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=59651-422
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d08d8aa5-76a4-417a-a308-7d195865522f